Anthony T. Podany - Concepedia

Author

Anthony T. Podany

University of Nebraska Medical Center ORCID

Also Known As

A T Podany, A. Podany, A. T. Podany, Anthony Podany, Anthony T Podany, Anthony T. Podany, Eric L. Nuermberger, Felton-Coleman, Angela

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

University of Nebraska Medical Center Johns Hopkins University Nebraska Medical Center Johns Hopkins Medicine University of California San Diego

About

Anthony T. Podany is an author at University of Nebraska Medical Center specializing in medicine, pharmacology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	250
2	Social Sciences	1	1	29
3	Allergy	1	1	18
4	Biomedical Engineering	1	1	15
5	Diabetes	1	1	47

Anthony T. Podany

Publications

911

Citations

H-Index

Page 1

	Year	Citations
Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy Rajesh T. Gandhi, Joshua C. Cyktor, Ronald J. Bosch, The Journal of Infectious Diseases	2020	142
Plasma and intracellular pharmacokinetics of tenofovir in patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide Anthony T. Podany, Sara H Bares, Joshua P Havens, AIDS	2018	83
Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention Anthony T. Podany, Yajing Bao, Susan Swindells, Clinical Infectious Diseases	2015	73
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial Susan E. Dorman, Payam Nahid, Ekaterina V. Kurbatova, Contemporary Clinical Trials Pulmonary TuberculosisHigh-dose RifapentineMedicineTbtc Study 31/ActgTuberculosis	2020	55
Adipocytes impair efficacy of antiretroviral therapy Jacob Couturier, Lee C. Winchester, James Suliburk, Antiviral Research ObesityMetabolic SyndromeInflammationAntiretroviral TherapyTreatment And Prevention	2018	47
Long-acting formulations for the treatment of latent tuberculous infection: opportunities and challenges Susan Swindells, Marco Siccardi, S. E. Barrett, The International Journal of Tuberculosis and Lung Disease Pharmaceutical ScienceTuberculosis PreventionImmunologyPharmacotherapyAntimicrobial Chemotherapy	2018	46
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation Suyash Deodhar, Brady Sillman, Aditya N. Bade, Nature Communications	2022	44
The Lymphoid Tissue Pharmacokinetics of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide in HIV‐Infected Persons Courtney V. Fletcher, Anthony T. Podany, Ann Thorkelson, Clinical Pharmacology & Therapeutics	2020	34
Normalization of cell associated antiretroviral drug concentrations with a novel RPP30 droplet digital PCR assay Shetty Ravi Dyavar, Zhen Ye, Siddappa N. Byrareddy, Scientific Reports	2018	32
ACE-2, TMPRSS2, and Neuropilin-1 Receptor Expression on Human Brain Astrocytes and Pericytes and SARS-CoV-2 Infection Kinetics Malik Johid Reza, Arpan Acharya, Sean N. Avedissian, International Journal of Molecular Sciences Synaptic TransmissionImmunologyNeuropilin-1 Receptor ExpressionImmune SystemSynaptic Signaling	2023	29

Page 1